DX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dynex Capital (DX) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading essentially flat and the technical trend is weak, with downside bias still present. Options sentiment is mildly bullish, but not strong enough to override the lack of a clear price trend. With no recent news catalyst, no insider or congress buying signal, and mixed fundamentals, the best call right now is to hold and wait for a clearer entry rather than buying immediately.
DX closed at 13.31, just below the pivot at 13.522 and near support at 13.277. RSI_6 at 37.88 is neutral-to-weak, while the MACD histogram is negative and still expanding, which points to continued short-term softness. Moving averages are converging, so there is no confirmed bullish trend yet. The pattern-based trend data also implies near-term weakness, with a 60% chance of -0.82% next day, -2.42% next week, and -5.08% next month. Overall, the chart is not showing a clean buy setup.
Revenue in Q1 2026 grew 36.86% year over year, showing strong top-line expansion. The options market is leaning bullish, and Dynex's hedging portfolio was noted as performing well. There is also no recent negative news flow.
Gross margin also deteriorated sharply. Hedge funds and insiders are both neutral, and there is no recent congress trading activity. The stock trend model points to further short-term downside.
In Q1 2026, Dynex Capital reported revenue of $119.0 million, up 36.86% year over year, which is a strong growth trend on the top line. However, profitability remains weak: net income was -$83.02 million and EPS was -0.41, both still negative despite year-over-year improvement in the reported figures. Gross margin was -49.66, indicating continued pressure on earnings quality. For a long-term beginner investor, the growth is encouraging but not enough to offset the lack of profitability.
Recent analyst sentiment is mixed but slightly constructive. UBS raised its price target to $14.50 and kept a Neutral rating, while JonesResearch lowered its target to $14.75 but maintained a Buy rating after Q1, citing spread volatility as near-term noise and better deployment runway. Overall, Wall Street is not bearish, but it is also not strongly bullish. The pros view is that revenue growth, hedging performance, and favorable options sentiment could support the stock. The cons view is that earnings are still negative, technicals are weak, and analysts remain cautious rather than enthusiastic.
